Testing Trametinib and Dabrafenib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATCH-Subprotocol H)
Clinical trial NCT04439292 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04439292
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-04
- Primary completion
- 2023-11-27
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.